Carl Brown

The future of autonomous vehicles feels like a promise that gets made and broken constantly. Despite the barriers, incumbents and disrupters continue to invest heavily in the development and deployment of AVs, at a global scale. How far are we from mass adoption of AVs in the U.S.? What challenges need to be tackled around technology, regulation, and ethics? How will the adoption of AV disrupt the broader passenger vehicle value chain? In this article, Michael Lenox and I set out to find the answers. #AV #AutonomousVehicles #AI #DardenITA

18

The past two years have been challenging for investors in the healthcare provider sector– but underlying trends that make provider investments attractive persist. Focusing on four capabilities—patient engagement, care delivery, productivity solutions, and new opportunities—could help spur performance and ensure long-term viability. Learn more in our latest McKinsey Healthcare Blog. ⬇️

25

Joe Zaccaria and Lindsey Manning from KPMG US delve into how real-world data (RWD) is revolutionizing healthcare and life sciences. By embracing Generative AI and adhering to the latest FDA guidelines, early adopters are not only accelerating clinical development but also paving the way for value-based healthcare delivery. This strategic integration of RWD is enhancing patient outcomes and fostering significant industry partnerships. #RealWorldData #KPMGLifeSciences #HealthcareInnovation https://bit.ly/4daoyiM

5

For those interested in innovation in healthcare, I recommend checking out this recent episode of Alvarez & Marsal's "What's Your Moonshot?" podcast series. Two leaders from our Healthcare Industry Group interview Greg Simon, former Executive Director of the White House Cancer Moonshot Task Force, in a fascinating conversation on the notion of a futures market (much like a commodity futures market -- think Trading Places) to drive predictability, efficiency, and affordability in healthcare.

17

Over the past three months, Clebert Etheredge, Alexis Love Sullivan, Florian Wallner, and I have been actively investing on the Stock-Trak platform as part of our Investments class with Professor Bill Reese at Tulane University - A.B. Freeman School of Business. 🚀 The result? A profit of $177,949.42, translating to a 17.79% return, outperforming the S&P 500 benchmark by approximately 10%! 💡 Top-performing investments included: BITX ETF: +88.65% (boosted by Bitcoin's November rally) Coinbase: +86.20% EVgo: +67.75% LifeMD: +51.98% Hims & Hers Health: +44.25% Spotify: +42.41% 📄 We’ve also prepared a detailed investment report that you can check out. This experience was a fantastic opportunity to apply real-world strategies and analytics to portfolio management.

20

1 Comment

FTI Consulting's Jason Shafrin,PhD, and Jaehong Kim, PhD, have published an innovative study that reimagines how we evaluate healthcare technologies and treatments. Our new Generalized Cost-Effectiveness Analysis (GCEA) framework goes beyond traditional metrics to consider 15 key value elements that matter to society, including: -How treatments affect patient confidence and risk -Long-term benefits as treatments evolve -Impact on caregivers and communities -Broader societal benefits like workplace productivity Why this matters: Current methods often miss important benefits of new healthcare technologies. Our user guide makes it easier to capture these broader impacts, leading to better-informed healthcare decisions. Read our complete framework and user guide below. #Healthcare #HealthEconomics #ValueBasedCare #FTIConsulting #Research #HealthcareInnovation

1

As 2025 kicks off, I am keeping an eye on the key themes emerging for CPG firms navigating a dynamic market landscape. Despite some lingering economic headwinds - such as a potential rebound in inflation in some markets, slower-than-expected interest rate cuts, and geopolitical uncertainties - I believe 2025 holds potential for higher growth vs 2024, driven by strategic focal points, such as: 1️⃣ Targeted Innovation – Demonstrating alignment with (local/regional) consumer values will push brands in 2025 to innovate beyond the "typical" sustainability and wellness claims as done in previous years 2️⃣ Digital Transformation – In 2024, CPG firms made significant investments in AI, data analytics, and e-commerce capabilities to enhance operational efficiencies. In 2025, we’ll start to witness the effectiveness of these investments or whether firms will need to reassess their AI and cost-optimization strategies 3️⃣ Resilience & Agility – Since the COVID-19 crisis, firms have focused on building more flexible supply chains, pricing strategies, and cost management systems. Despite ongoing challenges, 2025 offers a clearer landscape compared to 2024, providing a better environment for assessing and executing investments. We are likely to witness a rise in inorganic growth initiatives While 2024 was a year of strategic reset, 2025 may be defined by the ability to deliver real value to consumers. What are your thoughts on the key growth drivers this year? #CPG #GrowthStrategy #MarketTrends #2025Strategy #CompetitiveGrowth

39

Our Spring 2024 Consumer Sentiment Survey is out! Check out the trends that are shaping consumer behavior this season 🛍️

5

President Trump’s second term marks a significant shift in the political landscape that could have considerable implications for the health industry. Check out PwC's analysis of what the health industry can expect from a second Trump presidency. https://pwc.to/3AzbllZ

3

Axios highlighted Bain analysis showing companies further accelerating reshoring and near-shoring amid heightened geopolitical uncertainties and rising costs. Hernan Saenz, head of Bain’s Performance Improvement practice, discussed the trend with Axios chief economics correspondent Neil Irwin. https://bit.ly/3BF3sfp

2

FTI Consulting's Jason Shafrin,PhD, and Jaehong Kim, PhD, have published an innovative study that reimagines how we evaluate healthcare technologies and treatments. Our new Generalized Cost-Effectiveness Analysis (GCEA) framework goes beyond traditional metrics to consider 15 key value elements that matter to society, including: -How treatments affect patient confidence and risk -Long-term benefits as treatments evolve -Impact on caregivers and communities -Broader societal benefits like workplace productivity Why this matters: Current methods often miss important benefits of new healthcare technologies. Our user guide makes it easier to capture these broader impacts, leading to better-informed healthcare decisions. Read our complete framework and user guide below. #Healthcare #HealthEconomics #ValueBasedCare #FTIConsulting #Research #HealthcareInnovation

1

Axios highlighted Bain analysis showing companies further accelerating reshoring and near-shoring amid heightened geopolitical uncertainties and rising costs. Hernan Saenz, head of Bain’s Performance Improvement practice, discussed the trend with Axios chief economics correspondent Neil Irwin. https://bit.ly/4fl5LSp

3

Deal activity remains lethargic as of September 2024 as it continues to be impacted by high capital costs and regulatory scrutiny. However, sectors like pharma services are showing growth, and projections suggest a rebound in 2025. Looking for more on the latest trends and transaction activity across the industry?

11

The holidays are here, and #retailers are unwrapping a season of steady sales. Bain-defined US retail sales grew 3.8% year over year in November, trailing last year’s 4.6% growth and October’s 5.7% growth, but slightly surpassing our full season forecast. The surprise has been stores doing better than expected and ecommerce has been doing worse than both expected and the last five months worth - will be interesting to see how the rest of the season plays out. https://bit.ly/3ZImfyh

6

Bain & Company’s 2024 Private Equity Midyear Report has arrived. Private equity’s two-year slide in deals, exits, and funds closed slowed in the first half of 2024, but activity remained tentative and momentum scarce. Dive into the full report here: https://atbain.co/4aJfHmo

7

Prepping for success in your case interview? 💼 Hear from our team as they share tips to help you be more confident in your problem-solving approach. Check out our resources to help you prepare for an interview #atBain: https://lnkd.in/d4j_Gvmn

5